Anthony Caggiano

Insider

First SEC filing: Feb. 7, 2023 · Latest: Feb. 7, 2023

On this page

Insider at Companies where this person is a reporting insider.
Insider transactions Every share this person bought or sold, from Form 4 filings.
Derivatives Options and other derivative holdings reported by this person.
Compensation Executive pay disclosed in company proxy statements.

Insider at

CGTX buying April 16, 2026

Insider transactions

1 buys (P) 0 sells (S) Net: $11,100 + 17 non-open-market transactions below Avg return of open purchases vs now: -12.9% last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

17 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
April 16, 2026	CGTX	P	10,000	$1.11	$11,100	874,906 Direct	+1.16%	Acquired	-12.9% (price as of 2026-08-20)
Feb. 15, 2026	CGTX	F	4,680	$1.12	$5,242	864,906 Direct	-0.54%	Disposed	-13.7% (price as of 2026-08-20)
Feb. 4, 2026	CGTX	F	26,919	$1.03	$27,727	869,586 Direct	-3.00%	Disposed	-6.1% (price as of 2026-08-20)
Feb. 3, 2026	CGTX	F	11,488	$1.12	$12,867	896,505 Direct	-1.27%	Disposed	-13.7% (price as of 2026-08-20)
Feb. 3, 2026	CGTX	A	400,000	—	—	907,993 Direct	+78.74%	Acquired	(price as of 2026-08-20)
Dec. 18, 2025	CGTX	F	20,280	$1.50	$30,420	507,993 Direct	-3.84%	Disposed	-35.5% (price as of 2026-08-20)
Dec. 18, 2025	CGTX	A	65,000	—	—	528,273 Direct	+14.03%	Acquired	(price as of 2026-08-20)
July 29, 2025	CGTX	F	20,281	$0.67	$13,588	463,273 Direct	-4.19%	Disposed	44.3% (price as of 2026-08-20)
July 29, 2025	CGTX	A	65,000	—	—	483,554 Direct	+15.53%	Acquired	(price as of 2026-08-20)
Feb. 15, 2025	CGTX	F	5,296	$0.59	$3,125	418,554 Direct	-1.25%	Disposed	63.9% (price as of 2026-08-20)
Feb. 4, 2025	CGTX	A	295,000	—	—	423,850 Direct	+228.95%	Acquired	(price as of 2026-08-20)
Feb. 3, 2025	CGTX	F	12,779	$0.67	$8,562	128,850 Direct	-9.02%	Disposed	44.3% (price as of 2026-08-20)
Feb. 15, 2024	CGTX	A	60,000	—	—	60,000 Direct	—	Acquired	(price as of 2026-08-20)
Feb. 15, 2024	CGTX	A	60,000	—	—	141,629 Direct	+73.50%	Acquired	(price as of 2026-08-20)
Feb. 3, 2024	CGTX	F	12,777	$2.29	$29,259	81,629 Direct	-13.53%	Disposed	-57.8% (price as of 2026-08-20)
Feb. 3, 2023	CGTX	A	94,406	—	—	94,406 Direct	—	Acquired	(price as of 2026-08-20)
Feb. 3, 2023	CGTX	A	94,406	—	—	94,406 Direct	—	Acquired	(price as of 2026-08-20)
March 23, 2022	CGTX	A	25,000	—	—	25,000 Direct	—	Acquired	(price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
Feb. 15, 2024	CGTX	Stock Option (Right to Buy)	Common Stock (60,000)	$1.98	Feb. 15, 2034	60,000	Acquired
Feb. 3, 2023	CGTX	Stock Option (Right to Buy)	Common Stock (94,406)	$2.12	Feb. 3, 2033	94,406	Acquired
March 23, 2022	CGTX	Stock Option (right to buy)	Common Stock (25,000)	$3.05	March 23, 2032	25,000	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

CGTX

M.D., Ph.D. Chief Medical Officer

Fiscal year	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension change	Other	Total
2024	$486,000	—	$376,200	$93,694	$172,072	—	$18,300	$1,146,266
2023	$446,250	—	$200,141	$155,708	$151,725	—	$18,300	$972,124
2022	$424,183	—	—	$57,784	$136,000	—	$18,300	$636,267

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.